Your Health, We Care
Another NameJyseleca、Fequintinib
IndicationsAdult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to various disease modifying antirheumatic drugs (DMARD).
Reg No.
Inspection NO.
When using fego tinib, it is necessary to strictly follow the doctor's guidance and be aware of possible side effects such as headache, nausea, vomiting, stomach pain, etc. More serious side effects may include insomnia, depression, fatigue, diarrhea, respiratory infections, etc.
Filgotinib is a prescription drug, and patients should undergo a comprehensive physical examination and inform their doctor of their medical history and allergies before use.Given that the approval status of non gonotinib may vary in different countries and regions, patients should be aware of local regulations and policies when purchasing and using it.
Filgotinib
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient response or intolerance.
At present, there is insufficient data to confirm the safety of non gonotinib for pregnant and lactating women, therefore it is not recommended for use in these populations. If pregnant women become pregnant during medication, they should immediately stop using it and consult a doctor.
For elderly patients, especially those over 75 years old or with kidney problems, doctors may recommend taking a daily dose of 100mg of non gonotinib instead of the usual 200mg dose. This is because the liver and kidney function of elderly patients may decrease, and they need to be used with extra caution.
The safety and efficacy of fego tinib have not been determined in patients under the age of 18, therefore its use in children and adolescents should be avoided.
Drug overdose is not yet clear.
It should be stored at -20 ° C.
As a JAK1 inhibitor, it may exert its effect by affecting intracellular signaling pathways rather than directly eliminating them through metabolism in organs such as the liver.
from FDA，2023.07
